Maha Radhakrishnan - Director at Candel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director
Stock Symbol: CADL on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

There are no Buy or Sell transactions made by Maha Radhakrishnan since 11/29/2024

Holdings reported by Maha Radhakrishnan for Candel Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Stock Option (Right to Buy)	28.5K			Jun 4, 2025	Direct	Common Stock

Transactions reported by Maha Radhakrishnan for Candel Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.